title: Rebuttal from Drs Bilello and Murin.
authors: Department of Medicine, University of California San Francisco-Fresno Program, Fresno, CA.
authors: Kathryn L
authors: KL
authors: Bilello
authors: Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of California, Davis, School of Medicine, Sacramento, CA; Veterans Affairs Northern California Health Care System, Sacramento, CA. Electronic address: susan.murin@ucdmc.ucdavis.edu.
authors: Susan
authors: S
authors: Murin
mesh_terms: D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000639:trends*
chemical_list: D005343:Fibrinolytic Agents